ang3070
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04196179)
Timeline
Indications
Mechanism of action
- FibrocystinINHIBITOR
PKHD1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05387785 | Phase 1 | Jun 30, 2022 | Angion Biomedica Corp |
| NCT04939116 | Phase 2 | Oct 29, 2021 | Angion Biomedica Corp |
| NCT04196179 | Phase 1 | Dec 31, 2019 | Angion Biomedica Corp |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angion Biomedica Corp | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1